Trovagene, Genomac Expand Cancer Collaboration

Jan 21, 2015

|

NEW YORK (GenomeWeb) – Trovagene today announced the expansion of a clinical collaboration with Genomac Research Institute using the company's technology for the early detection of emerging oncogene mutations associated with resistance to targeted lung and colorectal cancer therapies.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

Large Breast Cancer Transcription-Wide Association Study Leads to New Candidate Risk Genes
Recurrent Rearrangements Identified in Rare Infant Soft Tissue Tumors
Top Five Articles on GenomeWeb Last Week: Oxford Nanopore, Agilent, Thermo Fisher, and More
Myriad Genetics Submits Supplementary PMA for BRACAnalysis CDx
Immuneering to Assist Dementia Discovery Fund in Quest for New Alzheimer's Drugs
People in the News: Michael McCartney, Rohan Hastie, John Ryals, Lawrence Firestone, More

The Scan

Theranos' Holmes Indicted

A federal grand jury has indicted Elizabeth Holmes and Ramesh Balwani for alleged wire fraud in conjunction with their activities at Theranos.

Mixed Reaction

Nature News reports that some developers are nervous about GitHub's acquisition by Microsoft.

Already Used

A direct-to-consumer genetic testing company sent out used spit kits, CNBC reports.

This Week in PLOS

In PLOS this week: comparison of commercial bisulfite kits, new method to predict essential proteins, and more

Jun

27

Featured Webinar

Clinical Utility of Liquid Biopsy for Targeted TKI Therapy in NSCLC

This webinar will present data from the FLAURA trial and show the clinical utility of liquid biopsy in identifying non-small-cell lung cancer (NSCLC) patients who may benefit from targeted TKI therapies.

Jul

19

Featured Webinar

Advances in NGS for Ultra-High Sensitivity Applications in Translational and Clinical Research

This webinar will discuss how ultra-highly sensitive and customizable targeted next-generation sequencing panels are applied in inherited disease research.

Main menu